000			03958nam a2200445 i 4500
999			_c383775 _d383775
001			383775
003			ES-MaUEC
005			20230102122146.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			201221s2021 si | o |||| 0|eng d
020			_a9789811593017
024	7		_a10.1007/978-981-15-9301-7 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC902 _b2021 EB
245	0	0	_aDiabetic Kidney Disease _cedited by Takashi Wada, Kengo Furuichi, Naoki Kashihara
250			_a1st edition 2021
264		1	_aSingapore _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VIII, 190 páginas) _b197 ilustraciones, 154 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aClinical Epidemiology -- The Japanese registries of diabetic nephropathy/diabetic kidney disease -- Diabetic kidney disease and cardiovascular disease -- Possible biomarkers for diabetic kidney disease -- Blood pressure management in diabetic kidney disease -- Glycemic control and future perspectives for treatment -- Nutrition and diet therapy for DKD -- Renal structural-functional relationships at the early stage of diabetic nephropathy among types 1 and 2 diabetes - Similarity and difference -- Study at AMED collecting 600 biopsy-proven diabetic nephropathy -- Evaluation of diabetic kidney lesions -- Nephrosclerosis and diabetic kidney disease -- Pathologic aspects I. Non diabetic-renal disease (NDRD) and diabetic kidney disease (DKD) -- Experimental Animal Models of Diabetic Kidney Disease.
520	3		_aThis book presents the latest information on the clinical-pathological features of diabetic kidney disease. The data included is based on a cohort study of biopsy-proven diabetic nephropathy patients and nephrosclerosis patients, who were observed over a long term, and on the long-term registry for diabetic nephropathy (diabetic kidney disease) in Japan. It provides a clinical-pathological axis in clinical settings, including differential pathological/clinical diagnoses of CKD in diabetic patients (e.g. the presence of "classic" diabetic nephropathy and/or nephrosclerosis and/or other primary kidney diseases). The abundant biopsy specimens with long-term medical records provide a detailed pathological and clinical description. The book also includes urine-sample data for developing and validating possible candidates for novel biomarkers for diabetic kidney disease. Many countries, including Japan, have ageing populations, in which nephrosclerosis contributes to the progression of kidney lesions in patients with diabetic kidney disease. As such, a comparison of a diabetic nephropathy cohort with nephrosclerosis is indispensable to offer better treatments. This comprehensive and informative book is an indispensible reference resource for all physicians and researchers in the field of nephrology and diabetes
988			_aSpringer_Medicine_2021
650		7	_2embne _9168885 _aRiñones _xEnfermedades
650		7	_2embne _9171495 _aDiabetes _xComplicaciones
700	1		_aWada, Takashi _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aFuruichi, Kengo _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKashihara, Naoki _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811593000
776	0	8	_iPrinted edition: _z9789811593024
776	0	8	_iPrinted edition: _z9789811593031
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-9301-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b11/2022 _dz _eb _zSI